Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis
NCT00385645
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
255
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Combivir+Kaletra
DRUG:
Combivir+Reyataz
Sponsor
Hospital Clinic of Barcelona